These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 22682762)

  • 1. Sale strategies of pharmaceutical companies in a "pharmerging" country: the problems will not improve if the gaps remain.
    Civaner M
    Health Policy; 2012 Aug; 106(3):225-32. PubMed ID: 22682762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug companies monitor prescriptions and sales to fine-tune their marketing strategies.
    Prescrire Int; 2010 Jun; 19(107):140-1. PubMed ID: 20738051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [An analysis of the pharmaceuticals market in Vietnam].
    Simonet D
    Sante; 2001; 11(3):155-60. PubMed ID: 11641078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "But doctors do it...": nurses' views of gifts and information from the pharmaceutical industry.
    Jutel A; Menkes DB
    Ann Pharmacother; 2009 Jun; 43(6):1057-63. PubMed ID: 19470854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are gifts from pharmaceutical companies ethically problematic? A survey of physicians.
    Brett AS; Burr W; Moloo J
    Arch Intern Med; 2003 Oct; 163(18):2213-8. PubMed ID: 14557219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exposure of medical students to pharmaceutical marketing in primary care settings: frequent and influential.
    Sarikaya O; Civaner M; Vatansever K
    Adv Health Sci Educ Theory Pract; 2009 Dec; 14(5):713-24. PubMed ID: 19184498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exposing nursing students to the marketing methods of pharmaceutical companies.
    Civaner M; Sarikaya O; Alici SU; Bozkurt G
    Nurs Ethics; 2008 May; 15(3):396-410. PubMed ID: 18388173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Qualitative insights into promotion of pharmaceutical products in Bangladesh: how ethical are the practices?
    Mohiuddin M; Rashid SF; Shuvro MI; Nahar N; Ahmed SM
    BMC Med Ethics; 2015 Dec; 16(1):80. PubMed ID: 26625723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perceptions and Attitudes of Egyptian Health Professionals and Policy-Makers towards Pharmaceutical Sales Representatives and Other Promotional Activities.
    Kamal S; Holmberg C; Russell J; Bochenek T; Tobiasz-Adamczyk B; Fischer C; Tinnemann P
    PLoS One; 2015; 10(10):e0140457. PubMed ID: 26473484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A proposal for the prevention of ethical problems related to drug promotion: a national network for drug information].
    Civaner M
    Turk Psikiyatri Derg; 2008; 19(3):310-7. PubMed ID: 18791884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New ways of insulin delivery.
    Heinemann L
    Int J Clin Pract Suppl; 2010 Feb; (166):29-40. PubMed ID: 20377662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Global marketing of cholesterol-lowering drugs as therapy.
    Elimimian JU; Gilmore JM; Singletary TJ
    J Hosp Mark Public Relations; 2006; 16(1-2):15-28. PubMed ID: 17194684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Jordanian pharmaceutical companies: are their marketing efforts paying off?
    Al-Shaikh MS; Torres IM; Zuniga MA; Ghunaim A
    Health Mark Q; 2011 Apr; 28(2):174-89. PubMed ID: 21590563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ethics of the medical-pharmaceutical relationship.
    Vashi NA; Latkowski JA
    Clin Dermatol; 2012; 30(2):188-91. PubMed ID: 22330662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ethics in pharmaceutical advertising.
    Lober CW
    Dermatol Clin; 1993 Apr; 11(2):285-8. PubMed ID: 8477540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are marketing campaigns in Taiwan by foreign tobacco companies targeting young smokers?
    Wen CP; Chen T; Tsai YY; Tsai SP; Chung WS; Cheng TY; Levy DT; Hsu CC; Peterson R; Liu WY
    Tob Control; 2005 Jun; 14 Suppl 1(Suppl 1):i38-44. PubMed ID: 15923447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The promise of pharmacogenetics: assessing the prospects for disease and patient stratification.
    Smart A; Martin P
    Stud Hist Philos Biol Biomed Sci; 2006 Sep; 37(3):583-601. PubMed ID: 16980196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malaria healthcare policy change in Kenya: implications on sales and marketing of antimalarials.
    Ngure PK; Nyaoke L; Minja D
    J Vector Borne Dis; 2012 Mar; 49(1):27-32. PubMed ID: 22585240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Who's buying lunch: are gifts to surgeons from industry bad for patients?
    Grant DC; Iserson KV
    Thorac Surg Clin; 2005 Nov; 15(4):533-42. PubMed ID: 16276818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "Asset exchange"-interactions between patient groups and pharmaceutical industry: Australian qualitative study.
    Parker L; Fabbri A; Grundy Q; Mintzes B; Bero L
    BMJ; 2019 Dec; 367():l6694. PubMed ID: 31831471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.